Ljubljana S.E.
06:00:00 2024-05-30 pm EDT
5-day change
1st Jan Change
130
EUR
+2.77%
+1.96%
+18.18%
Krka Provides Sales Guidance for the First Half of 2015
June 18, 2015 at 10:10 am EDT
Krka provided sales guidance for the first half of 2015. The company expected consolidated sales to drop 3% to EUR 580 million to EUR 662 million.
Transcript : Krka, d. d., Q1 2024 Earnings Call, May 16, 2024
May. 16
Krka, d. d. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 16
CI
Tranche Update on Krka, d. d.'s Equity Buyback Plan announced on July 20, 2023.
Mar. 14
CI
Krka, d. d. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 14
CI
Laurus Labs Limited Reaches to Agreement with Krka to Establish Joint Venture Company in Hyderabad, India Namely Krka Pharma Pvt. Ltd
Jan. 25
CI
Tranche Update on Krka, d. d.'s Equity Buyback Plan announced on August 3, 2020.
Jan. 25
CI
Tranche Update on Krka, d. d.'s Equity Buyback Plan announced on July 20, 2023.
Nov. 16
CI
Krka, d. d. Reports Earnings Results for the Nine Months Ended September 30, 2023
Nov. 16
CI
Krka, d. d. commences an Equity Buyback Plan for 1,452,216 shares, representing 4.69% of its issued share capital, under the authorization approved on July 6, 2023.
23-07-20
CI
Tranche Update on Krka, d. d.'s Equity Buyback Plan announced on August 3, 2020.
23-07-20
CI
Krka, d. d. Reports Earnings Results for the Half Year Ended June 30, 2023
23-07-20
CI
Krka, d. d.'s Equity Buyback announced on August 3, 2020, has expired with 593,278 shares, representing 1.9% for ?54.83 million.
23-07-05
CI
Krka, d. d. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-18
CI
Tranche Update on Krka, d. d.'s Equity Buyback Plan announced on August 3, 2020.
23-05-18
CI
Krka, d. d. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-16
CI
Tranche Update on Krka, d. d.'s Equity Buyback Plan announced on August 3, 2020.
23-03-16
CI
Krka Reportedly Eyes Promoter Stake in Unichem Laboratories
23-01-30
CI
Tranche Update on Krka, d. d.'s Equity Buyback Plan announced on August 3, 2020.
22-11-17
CI
Krka, d. d. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-11-17
CI
Tranche Update on Krka, d. d.'s Equity Buyback Plan announced on August 3, 2020.
22-07-21
CI
Krka, d. d. Reports Earnings Results for the Half Year Ended June 30, 2022
22-07-21
CI
Krka, d. d. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-19
CI
Tranche Update on Krka, d. d.'s Equity Buyback Plan announced on August 3, 2020.
22-03-30
CI
Krka, d. d. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-17
CI
Russia-Ukraine Tensions Seen Affecting Mining, Energy and Grain Sectors -- Analysis
22-01-27
DJ
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
More about the company
Average target price
131.2
EUR
Spread / Average Target
+0.94%
Consensus
1st Jan change
Capi.
+18.18% 4.35B +15.91% 41.97B +22.20% 22.34B +18.48% 15.25B +16.12% 14B +45.12% 12.06B -10.06% 6.8B -0.05% 6.79B -8.87% 5.73B +14.18% 5.49B
Generic Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
KRKA, D. D. 
